Efficacy of a 1-week course of proton-pump inhibitor-based triple therapy for eradicating Helicobacter pylori in patients with and without chronic renal failure.
Mak, Siu-ka; Loo, Ching-kong; Wong, Alfred M C; Wong, Ping-nam; Lo, Kin-yee; Tong, Gensy M W; Lam, Eric K M; Wong, Andrew K M.
Am J Kidney Dis
; 40(3): 576-81, 2002 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12200810
Evaluation of the efficacy and safety of the hybrid scheme for eradication therapy of Helicobacter pylori infection.
Efficacy and safety of the use of rebamipide in the scheme of triple eradication therapy of Helicobacter pylori infection: a prospective randomized comparative study.
First-line treatment of Helicobacter pylori in Lebanon: Comparison of bismuth-containing quadruple therapy versus 14-days sequential therapy.
Antibiomania : penser au syndrome maniaque secondaire à une antibiothérapie.
THE LONG - TERM RESULTS OF USEFUL ERADICAION PATIENTS WITH PEPTIC ULSERS (a five-year monitoring).
The Effect of Probiotics on Gut Microbiota during the Helicobacter pylori Eradication: Randomized Controlled Trial.
Helicobacter pylori Eradication with Proton Pump Inhibitors or Potassium-Competitive Acid Blockers: The Effect of Clarithromycin Resistance.
Low rate of recurrence of Helicobacter pylori infection in spite of high clarithromycin resistance in Pakistan.
[Amoxicillin-Clarithromycin-Containing Bismuth Quadruple Therapy for Primary Eradication of Helicobacter pylori].
Comparative Study of Clarithromycin- versus Metronidazole-Based Triple Therapy as First-Line Eradication for Helicobacter pylori.